MDLN earnings: real EPS beat/miss history, analyst consensus Buy, P/E 30.73. Updated 2026-07-23.
Medline (MDLN) Research Hub
Medline (MDLN) trades on NASDAQ, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-09-11, shares last closed at 32.53 USD (-4.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 30.73, market cap 31.85B. This hub links to the full technical, earnings and options research available for MDLN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 32.53 USD (-4.46%) |
| 52-week range | 31.87 USD – 43.64 USD |
| Trend regime | Range |
| 14-day RSI | 38.4 (Bearish) |
| Trailing P/E | 30.73 |
| Market cap | 31.85B |
| Dividend yield | 0.00% |
Available research for MDLN
Covered Call on MDLN: how it works, illustrative setup around the real 32.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MDLN: how it works, illustrative setup around the real 32.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MDLN: how it works, illustrative setup around the real 32.53 USD price, max profit/loss, breakeven and when to use it. Educational.
MDLN technical analysis: range, last 32.53 USD, RSI 38.4, 52w range 31.87 USD–43.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MDLN in?
Medline (MDLN) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, US.
Is MDLN in an uptrend or downtrend?
As of 2026-09-11, MDLN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MDLN's trailing P/E ratio?
MDLN's trailing P/E is 30.73, with a market cap of 31.85B. See the earnings research page for full valuation detail.